High neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are associated with worse progression-free survival and 5-year overall survival in patients with ovarian cancer. The ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...

CLEVELAND, Ohio—Cleveland Clinic researchers believe they may have discovered one of the ways that ovarian cancer cells resist chemotherapy. The results may help them identify patients unlikely to ...

In general, getting screened for cancer seems like the responsible thing to do, since preventing the disease is always better than treating it once it takes hold. But the latest research shows that ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Researchers at The University of Queensland have developed gold nanoparticles capable of highlighting faint cancer markers in non-invasive samples like urine, saliva, or blood. Mesoporous gold ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel tumor ...